Technology

Chemotype Evolution rapidly evolves fragments into novel leads using an empirical, iterative, target-directed screening approach....learn more

Therapeutics

By combining innovation with safe, validated small molecules, Carmot is creating novel drugs to treat inflammation, cancer, and metabolic diseases

December 8, 2011

Carmot Therapeutics wins NSF SBIR Phase II award to discover novel anticancer leads and further develop its proprietary technology, Chemotype Evolution 

Carmot Therapeutics announced today that it has been awarded a Phase II Small Business Innovation Research (SBIR) award from the National Science Foundation (NSF) to use its proprietary technology for discovering drugs that fight cancer....more